Increasing complaints about heel bruising in infants following blood-spot collection raised concerns about the best option for collecting blood from infants. A team from Mayo Clinic evaluated the practice of warming the heel prior to puncture, using venipuncture instead of heel puncture, and infant distress as a result of either heel puncture or venipuncture.
The steering committee for the Karolinska Institutet and Mayo Clinic partnership recently announced that the grant written by Andrew Norgan, M.D., Ph.D., and Elissa Hall for the Mayo Clinic PathWays Online “Case of the Week” has been selected for funding by a 2017 travel award.
Identifying the correct test for your patient is always critical. When it comes to hemophilia, there is significant confusion about which tests to order, resulting in about 25% of orders being cancelled after review by Mayo’s genetic counselors. In this two-part presentation, Lea Coon, C.G.C., walks you through the information that you need to correctly select testing for hemophilia A or B.
Programmed cell death ligand 1 (PD-L1) is a protein that can be expressed on tumor cells and immune cells. Anja Roden, M.D., discusses the role of PD-1 – PD-L1 interaction in the immune system and the challenges of PD-L1 testing.
Knowing which test is the correct test can be difficult. Ordering the wrong test can provide misleading results and increase costs to the patient. In this case review, Sarah Kerr, M.D., explains similarities and differences between mismatched repair defects and microsatellite instability when screening patients for Lynch syndrome.